Detection of nucleic acid sequence differences by comparative genomic hybridization

• US 9,809,841 B2
• Filed: 04/20/2016
• Issued: 11/07/2017
• Est. Priority Date: 02/17/2004
• Status: Expired due to Fees

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Albertson, Donna G., Pinkel, Daniel, Fridlyand, Yevgeniya, Huey, Bing, Snijders, Antoine
• Primary Examiner(s): THOMAS, DAVID C
• Application Number:
  US15/134,331
• Publication Number:
  US 20160340718A1
• Time in Patent Office: 566 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6809 Methods for determination or identification of nucleic acids involving differential detection

Abstract

The present invention provides a method of detecting nucleotide sequence differences between two nucleic acid samples. The method employs a comparative genomic hybridization (CGH) technique to analyze the sequence differences between the samples. This method permits the identification of small sequence differences (e.g., sequence divergence of 1% or less) in nucleic acid samples of high complexity (e.g., an entire genome).

Claims

1. An array Comparative Genomic Hybridization (CGH) method of detecting one or more nucleotide sequence differences in nucleic acid sequences in a first sample relative to nucleic acid sequences in a second sample, said method comprising:

(a) labeling nucleic acids from each sample with a different label;

(b) contacting the labeled nucleic acids from each sample with target nucleic acids, wherein either the labeled nucleic acids or the target nucleic acids, or both, have had repetitive sequences, if initially present, blocked and/or removed; and

(c) comparing the intensities of the signals from labeled nucleic acids hybridized to the target nucleic acids to detect one or more nucleotide sequence differences between the samples, wherein;

said contacting comprises contacting the labeled nucleic acids from each sample with an array of target elements comprising the target nucleic acids;

said comparing comprises comparing the intensities of the signals from labeled nucleic acids hybridized to each target element; and

the sequence complexity of each target element is greater than about 50 kilobases and the sequence divergence between the samples is less than about 10%.

2. The method of claim 1, wherein the sequence complexity of each target element is between about 50 kilobases to about 500 kilobases.

3. The method of claim 1, wherein the sequence complexity of each target element is between about 75 kilobases and 300 kilobases.

4. The method of claim 1, wherein the sequence divergence between the samples is about 5% or less.

5. The method of claim 1, wherein the sequence divergence between the samples is about 1% or less.

6. The method of claim 1, wherein the target nucleic acids comprises a plurality of different genomic DNA molecules, selected from different loci in a reference genome.

7. The method of claim 6, wherein the plurality of different genomic DNA molecules is selected from at least about 1000 different loci in the reference genome.

8. The method of claim 6, wherein the plurality of different genomic DNA molecules is selected from at least about 5000 different loci in the reference genome.

9. The method of claim 6, wherein the plurality of different genomic DNA molecules is selected from at least about 10,000 different loci in the reference genome.

10. The method of claim 1, wherein the target nucleic acids are derived from a nucleic acid library.

11. The method of claim 10, wherein the target nucleic acids are derived from YAC, BAC, P1, PAC, or cosmid clones.

12. The method of claim 1, wherein the array is a microarray comprising at least 1000 target elements affixed to a 1 cm² region of substrate.

13. The method of claim 1, wherein the labeled nucleic acids comprise DNA molecules.

14. The method of claim 13, wherein the labeled nucleic acids comprise genomic DNA molecules.

15. The method of claim 1, wherein the labeled nucleic acids comprise RNA molecules synthesized using genomic DNA as a template.

16. The method of claim 1, wherein the labeled nucleic acids are derived from a nucleic acid library.

17. The method of claim 16, wherein the labeled nucleic acids are derived from YAC, BAC, P1, PAC, or cosmid clones.

18. The method of claim 1, wherein the samples comprise nucleic acids from different strains of the same species.

19. The method of claim 18, wherein the samples comprise nucleic acids from different mouse strains.

20. The method of claim 1, wherein the samples comprise nucleic acids from related individuals.

21. The method of claim 20, wherein:

one sample comprises nucleic acids from a parental strain or species that is crossed with another strain or species to produce an F1individual; and

another sample comprises nucleic acids from an individual resulting from the backcross of the F1 individual with the parental strain or species.

22. The method of claim 19 wherein the results of the comparison of a backcross individual to one of the parental strains or species are normalized by the results of a comparison of an F1 individual to one of the parental strains or species.

23. The method of claim 21, wherein the detection of one or more nucleotide sequence differences comprises determining whether the backcross individual is homozygous or heterozygous for the locus corresponding to each target element.

24. The method of claim 1, wherein the first sample is from an individual or plurality of individuals with a particular characteristic, and the second sample is from an individual or plurality of individuals that differ in that characteristic.

25. The method of claim 24, wherein the characteristic comprises the risk of developing a disease, and one or more nucleotide sequence differences at a locus corresponding to a target element indicates that the locus may influence the risk of developing the disease, or that it may be linked to such a locus.

26. The method of claim 1, wherein the labeled nucleic acids from at least one sample have a complexity of at least about 100 kilobases.

27. The method of claim 1, wherein the labeled nucleic acids from at least one sample have a complexity of at least about 10⁴ kilobases.

28. The method of claim 1, wherein the one or more nucleotide sequence differences detected comprise loss of heterozygosity at one or more loci in the first sample relative to the second sample, and the samples comprise nucleic acids from related individuals.

29. The method of claim 1, wherein the one or more nucleotide sequence differences detected comprise loss of heterozygosity at one or more loci in the first sample relative to the second sample, and the first sample comprises nucleic acids from a first F1 individual produced by crossing a parental strain with another strain.

30. The method of claim 29, wherein the second sample comprises nucleic acids from a second F1 individual produced from said cross.

31. The method of claim 29, wherein the second sample comprises nucleic acids from a tumor from the first F1 individual.

32. The method of claim 1, wherein the one or more nucleotide sequence differences detected comprise loss of heterozygosity at one or more loci in the first sample relative to the second sample, and the first sample is from an individual or plurality of individuals with a particular characteristic, and the second sample is from an individual or plurality of individuals that differ in that characteristic.

33. The method of claim 32, wherein the characteristic comprises the risk of developing a disease, and loss of heterozygosity at a locus indicates that the locus may influence the risk of developing the disease, or that it may be linked to such a locus.